Deregulated microRNAs and Adiponectin in Postmenopausal Women with Breast Cancer

被引:14
|
作者
Isabel Pena-Cano, Maria [1 ]
Saucedo, Renata [2 ]
Morales-Avila, Enrique [1 ]
Valencia, Jorge [2 ]
Zavala-Moha, Jose A. [3 ]
Lopez, Adriana [4 ]
机构
[1] Univ Autonoma Estado Mexico, Fac Chem, Toluca, Mexico
[2] Inst Mexicano Seguro Social, Endocrine Res Unit, Natl Med Ctr, Cuauhtemoc 330, Mexico City 06720, DF, Mexico
[3] Reg Hosp 251, Inst Mexicano Seguro Social, Oncol Dept, Mexico City, DF, Mexico
[4] Reg Hosp 251, Inst Mexicano Seguro Social, Pathol Dept, Mexico City, DF, Mexico
关键词
Breast cancer; Menopause; Obesity; MicroRNA; Adiponectin; Leptin; Insulin-like growth factors; MIR-17-92; CLUSTER; OBESITY; OVERWEIGHT; EXPRESSION; LEPTIN; SERUM; METABOLISM; MECHANISMS; MORTALITY; DIAGNOSIS;
D O I
10.1159/000496340
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: Obesity is a risk factor for breast cancer (BC). Some mechanisms through which obesity can lead to cancer development are insulin-like growth factors (IGFs), adipokines, and microRNAs (miRs). The objective of the study was to determine whether miR-17-5p, miR-195-5p, and miR-2213p expressions were deregulated in serum samples of obese and nonobese postmenopausal women with BC. In addition, insulin, adiponectin, leptin and IGFs were analyzed. Methods: Fifty postmenopausal women with newly diagnosed BC and 50 postmenopausal healthy women were evaluated. Differences in miRs between BC and healthy cases and between obese and lean participants were analyzed. Receiver operating characteristic curves for miRs for discriminating patients with or without BC were established, and relationships between the miRs, adipokines, and breast tumor characteristics were also investigated. Results: miR-17-5p and miR-195-5p were higher in patients with BC in comparison to the controls, while miR-221-3p and adiponectin were significantly lower. Increased levels of miR-195-5p allowed the differentiation of BC from controls with a sensitivity of 83.3 and a specificity of 78.3%, and were associated with lobular and poorly differentiated cancer. There was no difference in miRs levels between obese and lean groups. Conclusions: Circulating miRs and adiponectin were deregulated in postmenopausal women with BC. (C) 2019 S. Karger AG, Basel
引用
收藏
页码:369 / 377
页数:9
相关论文
共 50 条
  • [41] Exemestane for Breast-Cancer Prevention in Postmenopausal Women
    Goss, Paul E.
    Ingle, James N.
    Ales-Martinez, Jose E.
    Cheung, Angela M.
    Chlebowski, Rowan T.
    Wactawski-Wende, Jean
    McTiernan, Anne
    Robbins, John
    Johnson, Karen C.
    Martin, Lisa W.
    Winquist, Eric
    Sarto, Gloria E.
    Garber, Judy E.
    Fabian, Carol J.
    Pujol, Pascal
    Maunsell, Elizabeth
    Farmer, Patricia
    Gelmon, Karen A.
    Tu, Dongsheng
    Richardson, Harriet
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (25): : 2381 - 2391
  • [42] Managing the risk of breast cancer in postmenopausal women: introduction
    Vogel, Victor G.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (04): : 779 - 781
  • [43] SEXUALITY AFTER BREAST CANCER SURGERY IN POSTMENOPAUSAL WOMEN
    Kaabia, O.
    Bouchahda, R.
    Hidar, S.
    Bibi, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A40 - A40
  • [44] Sexual function and chemotherapy in postmenopausal women with breast cancer
    José Antônio Crespo Cavalheiro
    Ana Cristina da Costa Bittelbrunn
    Carlos Henrique Menke
    Jorge Villanova Biazús
    Nilton Leite Xavier
    Rodrigo Cericatto
    Fernando Schuh
    Caroline Vieira Pinheiro
    Eduardo Pandolfi Passos
    BMC Women's Health, 12
  • [45] Treatment of postmenopausal women with hormone responsive breast cancer
    Winer, E.
    BREAST, 2009, 18 : S16 - S17
  • [46] Morphological and immunohistochemical features of breast cancer in postmenopausal women
    Bucur, A.
    Anderco, D.
    Lazureanu, C.
    Muresan, A.
    Suciu, C.
    Herman, D.
    Taban, S.
    Dema, A.
    VIRCHOWS ARCHIV, 2017, 471 : S296 - S296
  • [47] Sexual function and chemotherapy in postmenopausal women with breast cancer
    Crespo Cavalheiro, Jose Antonio
    da Costa Bittelbrunn, Ana Cristina
    Menke, Carlos Henrique
    Biazus, Jorge Villanova
    Xavier, Nilton Leite
    Cericatto, Rodrigo
    Schuh, Fernando
    Pinheiro, Caroline Vieira
    Passos, Eduardo Pandolfi
    BMC WOMENS HEALTH, 2012, 12
  • [48] Economic impact of recurrence in postmenopausal women with breast cancer
    Stern, L.
    Kaura, S.
    Mody-Patel, N.
    Ogbonnaya, A.
    Wiederkehr, D.
    EJC SUPPLEMENTS, 2008, 6 (07): : 135 - 135
  • [49] Individual breast cancer risk assessment in postmenopausal women
    de Souza, RM
    Lazzaron, AR
    Defferrari, R
    Borba, AA
    Scherer, L
    Frasson, AL
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S24 - S25
  • [50] Is There a Relationship between Diet and Breast Cancer in Postmenopausal Women?
    Pereira, Nadia Raci Marques
    Naufel, Maria Fernanda
    Tufik, Sergio
    Hachul, Helena
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2022, 75 (01): : 140 - 142